Quantum-Si Executive Sells Over $4k in Company Stock
Northwestern Proteomics Center of Excellence Partners With Quantum-Si for Webinar on Advancing Proteoform Analysis With Top-Down Mass Spectrometry and Single-Molecule Sequencing
Quantum-Si to Host Investor & Analyst Event in New York City on November 20th, 2024
Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development
Correct: Quantum-Si: Todd Bennett Named New Chief Comml Officer, Effective Sept. 17, Not Sept. 16 >QSI
Quantum-Si Appoints Todd Bennett as Chief Commercial Officer
Quantum-Si Announces Executive Leadership Transition
Express News | Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company Into a Leading Proteomic Tool Provider
Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Pleasing Signs As A Number Of Insiders Buy Quantum-Si Stock
Charles Kummeth Bought 92% More Shares In Quantum-Si
Quantum-Si Shares Updated Corporate Presentation
Buy Rating Affirmed for Quantum-Si on Strong Financials and Promising Product Pipeline
Earnings Call Summary | Quantum-Si(QSI.US) Q2 2024 Earnings Conference
Quantum-Si Incorporated (QSI) Q2 2024 Earnings Call Transcript
CORRECTION: Quantum-Si Q2 EPS $(0.16) Beats $(0.19) Estimate, Sales $622.00K Miss $680.00K Estimate
Quantum-Si Sees FY24 Revenue $3.7M-$4.2M Vs $4.024M Est.
10-Q: Q2 2024 Earnings Report
Earnings Flash (QSI) QUANTUM-SI INCORPORATED Posts Q2 Revenue $622,000, Vs. Street Est of $0.68M
Express News | Quantum-Si Q2 EPS USD -0.16